📚 PASS Investment Adviser (Level 2) Difficulty: Beginner ℹ️ Info   ~5 min read
📌 Chapter 1.4 — Concepts in Insurance

Imagine you are reviewing a client’s portfolio transition, specifically assessing the risk-mitigation layer. As you compare their term life insurance policy against their newly proposed critical illness cover, you notice both policies function similarly in your cash-flow projections. While one covers mortality and the other covers specific morbidity events, both are structured as defined benefit contracts in the Indian insurance market. For an analyst, this distinction is critical because it shifts your focus from reimbursement ratios—common in health indemnity plans—to sum assured valuation.

Defined benefit plans are designed to bypass the complexity of quantifying a precise financial loss. In life insurance, the loss of human capital is theoretically infinite, making a predetermined payout the only practical solution. Similarly, critical illness policies operate on a ’lump sum’ basis, paying out the full sum assured upon the diagnosis of a listed condition like cancer or cardiac arrest.

Because these policies do not require the submission of hospital bills for specific cost reimbursement, they provide liquidity that can be used for any purpose, from high-quality medical treatment to debt servicing or income replacement.

From a financial planning perspective, this similarity means you should evaluate both instruments using the same methodology: sufficiency testing based on the client’s long-term financial liabilities. When modeling, you treat the death benefit and the critical illness payout as ’event-triggered cash inflows’ rather than ‘offsetting expense items.’ This allows you to integrate them cleanly into a net worth analysis. If a client is diagnosed with a covered critical illness, the policy acts as a liquidity bridge, preventing the premature liquidation of equity or mutual fund holdings to cover unforeseen expenses.

Consider a case where an investor holds a ₹50 lakh term policy and a ₹20 lakh critical illness rider. Should the investor face a diagnosis, the payout provides the capital needed to maintain their lifestyle without disrupting their investment strategy. The primary difference for you as an analyst is the termination event: life insurance terminates at death, whereas critical illness coverage often terminates or reduces after a single successful claim. Understanding that both serve as ’lump-sum’ buffers is essential when mapping these tools to a client’s risk management framework.

Nuance

⚠️ Nuance
A common professional misconception is that critical illness policies are simply a subset of health insurance. In reality, while sold by health or life insurers, they are structurally distinct because they do not operate on an indemnity basis. Analysts often err by applying indemnity-based logic—expecting the insurer to track actual medical costs—when in fact, the payout is triggered solely by the diagnostic report, regardless of the treatment cost incurred.

Check Your Understanding

Practice Question 1

An investor holds a critical illness policy and suffers a heart attack that triggers a payout of ₹10 lakh. The actual medical expenses incurred amount to ₹6 lakh. Which statement best describes the insurance company’s liability in the Indian regulatory context?

Practice Question 2

When incorporating both life insurance and critical illness policies into a financial model, which common characteristic allows an analyst to treat them as ’liquidity events'?

This is a companion read for Section 1.4 — Concepts in Insurance from PASS Investment Adviser (Level 2) by Akhilesh Gururani, available on Amazon Kindle.

Copyright © 2026 Akhilesh Gururani. All rights reserved.